Back
Pliant Therapeutics Vs. Avalo Therapeutics Industry Stock Comparison
Sell
26
PLRX
Pliant Therapeutics
Last Price:
25.60
Seasonality Move:
-19.58%
Sell
9
AVTX
Avalo Therapeutics
Last Price:
1.80
Seasonality Move:
-11.89%
Sell
26
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy, Sell or Hold?
- The current Pliant Therapeutics [PLRX] share price is $25.60. The Score for PLRX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- PLRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
9
Avalo Therapeutics (AVTX)
is a Sell
Is Avalo Therapeutics a Buy, Sell or Hold?
- The current Avalo Therapeutics [AVTX] share price is $1.81. The Score for AVTX is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
- AVTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PLRX Stock Price Chart
What is Pliant Therapeutics's stock price today?
-
The Pliant Therapeutics share price today is $25.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing slight selling pressure.
AVTX Stock Price Chart
What is Avalo Therapeutics's stock price today?
-
The Avalo Therapeutics share price today is $1.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVTX is experiencing selling pressure, which indicates risk of future bearish movement.
PLRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.07 | Sell |
| Relative Strength Index (14 RSI): | 32.37 | Sell |
| Chaikin Money Flow: | -220949 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.35 - 31.47) | Sell |
| Bollinger Bands (100): | (19.04 - 30.68) | Buy |
AVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 22.11 | Sell |
| Chaikin Money Flow: | -4029 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.14 - 2.86) | Sell |
| Bollinger Bands (100): | (2.99 - 5.77) | Sell |
PLRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.95 | Sell |
| 20-day SMA: | 28.96 | Sell |
| 50-day SMA: | 29.94 | Sell |
| 200-day SMA: | 21.47 | Buy |
| 8-day EMA: | 26.91 | Sell |
| 20-day EMA: | 28.3 | Sell |
| 50-day EMA: | 28.13 | Sell |
| 200-day EMA: | 22.56 | Buy |
AVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.16 | Sell |
| 20-day SMA: | 2.36 | Sell |
| 50-day SMA: | 3.2 | Sell |
| 200-day SMA: | 4.6 | Sell |
| 8-day EMA: | 2.09 | Sell |
| 20-day EMA: | 2.4 | Sell |
| 50-day EMA: | 3.1 | Sell |
| 200-day EMA: | 5.66 | Sell |
Pliant Therapeutics Earnings Growth & PLRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.20 per share.
Avalo Therapeutics Earnings Growth & AVTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $1.19 per share.
Pliant Therapeutics Technical Analysis
| Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | Mar-24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avalo Therapeutics Technical Analysis
| Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | Mar-24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||